Latest News and Press Releases

WESTPORT, Conn., March 30, 2026 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle-market businesses, today announced that it has entered into...

BOSTON, March 27, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and...

Virtual Event will feature Key Opinion Leaders (KOLs) Richard DiPaolo, PhD, and Jonathan Kay, MD, FACP, MACR Cue Biopharma management and KOLs will discuss CUE-401, the company’s lead asset for the...

New York City, NY, March 25, 2026 (GLOBE NEWSWIRE) -- Introduction In today’s skincare landscape, the conversation is gradually shifting. For years, the focus has largely been on covering...

YY Group estimates $34.3M in total assets and $13.6M in net assets for FY2025, equal to $8.03 and $3.18 per share after share consolidation.

Apolosign Digital Calendar: A subscription-free family hub for sync'd scheduling and tasks. Build kids' responsibility with rewards.

AGOURA HILLS, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), a leader in RNA-based therapeutics, announced today...

In a high-stakes, time-sensitive transaction highlighting both urgency and opportunity in today’s real estate market, Crown Guard Capital LLC has success

AGOURA HILLS, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), a leader in RNA-based therapeutics, announced today...

Allschwil, Switzerland, March 23, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...